• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2021, Vol. 23 ›› Issue (8): 622-625.

• 智慧监管专栏 • 上一篇    下一篇

我国药物临床试验期间药物警戒体系建设和思考

苏娴, 李艳蓉, 王海学*   

  1. 国家药品监督管理局药品审评中心, 北京 100022
  • 收稿日期:2021-09-24 修回日期:2021-06-24 出版日期:2021-08-28 发布日期:2021-08-28

Construction and Consideration of Pharmacovigilance System During Drug Clinical Trials#br# #br#

 SU Xian, LI Yanrong WANG Haixue*   

  1. Center for Drug Evalution,NMPABeijing 100022 China
  • Received:2021-09-24 Revised:2021-06-24 Online:2021-08-28 Published:2021-08-28

摘要: 药物警戒是发现、评价、理解和预防药品不良反应或其他任何可能与问题药物有关的科学研究和活动。临床试验期间药物警戒是药品全生命周期药物警戒的重要组成部分。在临床试验默示许可制提高了审评效率的同时,如何通过建立临床试验期间药物警戒体系来有效保护受试者和控制安全性风险,值得深入研究。本研究介绍了药物临床试验期间药物警戒法律法规体系建设和系统平台建设情况,概述了药物临床试验期间药物警戒体系在安全性报告监测和新冠肺炎药物/疫苗应急审批临床试验的监管成效,以及对提升临床试验期间药物警戒智慧监管能力的思考,以期为进一步完善我国药物临床试验期间药物警戒体系提供参考。
   

关键词: 临床试验, 药物警戒, 智慧监管, 药品审评

Abstract: Pharmacovigilance is the scientific research and activity that detects, evaluates understands and prevents various adverse reactions or problems related to drugs. Pharmacovigilance during clinical trials is an important part of the whole life cycle pharmacovigilance. While the clinical trial implied licensing system improves the review efficiency how to establish pharmacovigilance during clinical trials to control safety risks and protect the subjects is worth further study. This paper introduced the legal and regulatory system construction and the information systerm construction of pharmacovigilance system during clinical trials and summarized the effectiveness of pharmacovigilance system in monitoring safety report and the supervision of COVID-19 emergency varieties during clinical trials and discussed the thinking of improving the intelligent supervision ability of pharmacovigilance during clinical trials so as to provide reference for further improving the pharmacovigilance system during clinical trials in China.


Key words: Clinical trial , Pharmacovigilance , Intelligent supervision , Drug review

中图分类号: